Virtual Reality and D-Cycloserine in Combat Related Psycological Trauma in Burn Service Members
Status:
Withdrawn
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to begin the examination of the feasibility of using
Gradual Virtual Reality Exposure Therapy and D-Cycloserine (DCS) in the management of
posttraumatic psychological symptoms in burned OIF/OEF military combatants.
The purpose of a feasibility study is to determine if there is clinical utility in this
proposed treatment and to establish effective and safe treatment procedures. Given current
literature, the following hypotheses are generated:
Hypothesis 1: Virtual Reality Exposure and D-Cycloserine medication (VRE + DCS learning pill)
will result in clinically meaningful PTSD symptom reduction.
1. SMs will attain scores that are lower than initial measures for symptoms of PTSD
2. By the completion of VRE, Ss will attain scores in the sub-clinical range for measures
of clinical depression Hypothesis 2: SMs will report greater life satisfaction following
completion of VR+DCS treatment, as measured by scores on the Quality of Life Inventory
(QOLI) when compared to pre-treatment scores